Tropisetron: International drug information (concise)
For abbreviations, symbols, and age group definitions used in Lexicomp (
show table)
International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Navoban;
-
(AR) Argentina: Navoban;
-
(AT) Austria: Navoban;
-
(AU) Australia: Navoban | Tropisetron aft | Tropisetron myx;
-
(BE) Belgium: Novaban;
-
(BR) Brazil: Navoban;
-
(CL) Chile: Navoban;
-
(CN) China: He tai | Qi qiong | Sai ge en | Shu ou ting | Tropisetron Hydrochloride and Glucose | Tropisetron hydrochloride and sodium chloride;
-
(CO) Colombia: Navoban;
-
(CZ) Czech Republic: Navoban;
-
(DE) Germany: Navoban;
-
(DO) Dominican Republic: Navoban;
-
(EC) Ecuador: Navoban;
-
(EE) Estonia: Navoban;
-
(EG) Egypt: Navoban | Tropiresten;
-
(ES) Spain: Navoban;
-
(FI) Finland: Navoban;
-
(FR) France: Navoban | Tropisetron Dci;
-
(GB) United Kingdom: Navoban;
-
(HK) Hong Kong: Navoban | Setrovel;
-
(HU) Hungary: Navoban;
-
(ID) Indonesia: Navoban | Setrovel;
-
(IE) Ireland: Navoban;
-
(IT) Italy: Navoban;
-
(JO) Jordan: Navoban;
-
(KR) Korea, Republic of: Navoban;
-
(LB) Lebanon: Navoban;
-
(LT) Lithuania: Navoban;
-
(LU) Luxembourg: Navoban;
-
(MX) Mexico: Navoban;
-
(MY) Malaysia: Navoban;
-
(NL) Netherlands: Novaban;
-
(NO) Norway: Navoban;
-
(NZ) New Zealand: Navoban | Tropisetron aft;
-
(PE) Peru: Conimex | Navoban;
-
(PH) Philippines: Hensetron;
-
(PK) Pakistan: Navoban;
-
(PL) Poland: Navoban;
-
(PT) Portugal: Navoban;
-
(RU) Russian Federation: Navoban | Tropindolum;
-
(SA) Saudi Arabia: Navoban;
-
(SG) Singapore: Navoban;
-
(SK) Slovakia: Navoban;
-
(TH) Thailand: Navoban;
-
(TR) Turkey: Navoban;
-
(TW) Taiwan: Navoban;
-
(UY) Uruguay: Navoban
Index Terms
- Tropisetron Hydrochloride
Pharmacologic Category
-
Antiemetic; Selective 5-HT3 Receptor Antagonist
Reported Use
Prevention of nausea and vomiting induced by cytotoxic chemotherapy; treatment and prevention of postoperative nausea/vomiting
Dosage Range
Adults:
IV:
Chemotherapy-induced nausea and vomiting: 5 mg before chemotherapy on day 1.
Prevention of postoperative nausea/vomiting: 2 mg shortly before induction of anesthesia.
Treatment of postoperative nausea/vomiting: 2 mg as a single dose.
Oral: Chemotherapy-induced nausea and vomiting: 5 mg daily on days 2 through 6 following IV dose given on day 1.
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Solution, Injection: 1 mg/mL
Solution, Injection/Oral: 1 mg/mL
Topic 10440 Version 59.0